Oncogenes and tumor suppressor genes in squamous cell carcinoma of the tongue in young patients
- PMID: 25633809
- PMCID: PMC4413665
- DOI: 10.18632/oncotarget.2850
Oncogenes and tumor suppressor genes in squamous cell carcinoma of the tongue in young patients
Abstract
Objectives: The occurrence of squamous cell carcinoma of the tongue (SCCT) of young patients increased. There are still controversies about patient prognosis. The underlying molecular mechanisms remain unclear.
Methods: 276 patients (66 ≤45, 210 >45 years) with SCCT were included. Clinical parameters and survival data were assessed. Oncogenes and tumor suppressors were analyzed via immunohistochemistry (p53, CXCR4, p16, EGFR) and qPCR (CDK4, CDKN2A, TP53, MDM2, AKT1, PIK3CA, NRAS, HRAS, KRAS, HGF, MET, EGF, ATM, BRCA1, E2F1, FHIT, RUNX3, STK11, BCL2, CTNNB1).
Results: The median overall survival was 142 (≤45 years) and 34 months (>45 years) (p < 0.0001; HR [95%CI]: 0.37 [0.30-0.58]). Disease specific survival in patients ≤45 years was with 181 months significantly higher than in patients >45 years (p < 0.0001; HR [95%CI]: 0.33 [0.26-0.57]). Immunhistochemistry visualized a comparable expression of analyzed proteins. QPCR demonstrated in patients ≤45 years a higher expression of genes that are associated with carcinogenesis (CTNNB1, STK11, CDKN2A, HGF, MET) as well as tumor suppressors that constitute an enhanced radio-sensitivity (ATM, BRCA1E2F1, FHIT).
Conclusion: Derogation of the WNT-CTNNB1-STK11 and CDKN2A-HGF-MET pathway can constitute the carcinogenesis, while the higher expression of radio-sensitizers ATM, BRCA1E2F1 and FHIT can explain the better OS/DSS in young patients.
Conflict of interest statement
All authors sate no conflict of interest.
Figures



Similar articles
-
Comprehensive genomic profiling of head and neck squamous cell carcinoma reveals FGFR1 amplifications and tumour genomic alterations burden as prognostic biomarkers of survival.Eur J Cancer. 2018 Mar;91:47-55. doi: 10.1016/j.ejca.2017.12.016. Epub 2018 Jan 11. Eur J Cancer. 2018. PMID: 29331751
-
Ultra-deep targeted sequencing of advanced oral squamous cell carcinoma identifies a mutation-based prognostic gene signature.Oncotarget. 2015 Jul 20;6(20):18066-80. doi: 10.18632/oncotarget.3768. Oncotarget. 2015. PMID: 25980437 Free PMC article.
-
TP53 and CDKN2a mutations in never-smoker oral tongue squamous cell carcinoma.Laryngoscope. 2014 Jul;124(7):E267-73. doi: 10.1002/lary.24595. Epub 2014 Feb 20. Laryngoscope. 2014. PMID: 24431303
-
Head and neck squamous cell carcinoma: Ambiguous human papillomavirus status, elevated p16, and deleted retinoblastoma 1.Head Neck. 2017 Mar;39(3):E34-E39. doi: 10.1002/hed.24604. Epub 2016 Nov 8. Head Neck. 2017. PMID: 27859938 Free PMC article. Review.
-
Molecular biology of squamous cell carcinoma of the head and neck.J Clin Pathol. 2006 May;59(5):445-53. doi: 10.1136/jcp.2003.007641. J Clin Pathol. 2006. PMID: 16644882 Free PMC article. Review.
Cited by
-
Tongue carcinoma in young adults: a review of the literature.Acta Otorhinolaryngol Ital. 2018 Jun;38(3):175-180. doi: 10.14639/0392-100X-1932. Acta Otorhinolaryngol Ital. 2018. PMID: 29984792 Free PMC article. Review.
-
MicroRNA‑509 acts as a tumor suppressor in tongue squamous cell carcinoma by targeting epidermal growth factor receptor.Mol Med Rep. 2017 Nov;16(5):7245-7252. doi: 10.3892/mmr.2017.7531. Epub 2017 Sep 20. Mol Med Rep. 2017. Retraction in: Mol Med Rep. 2024 Mar;29(3):52. doi: 10.3892/mmr.2024.13176. PMID: 28944863 Free PMC article. Retracted.
-
Profiling the Tumor Immune Microenvironment of HPV-Associated Base of Tongue Squamous Cell Carcinoma.Onco Targets Ther. 2025 Feb 20;18:263-281. doi: 10.2147/OTT.S505376. eCollection 2025. Onco Targets Ther. 2025. PMID: 39995441 Free PMC article.
-
Unusual pattern: Diffuse pulmonary FDG uptake on PET/CT.Radiol Case Rep. 2024 Sep 28;19(12):6614-6617. doi: 10.1016/j.radcr.2024.09.069. eCollection 2024 Dec. Radiol Case Rep. 2024. PMID: 39380827 Free PMC article.
-
Comparison of Clinico-Demographic and Histological Parameters Between Young and Old Patients With Oral Squamous Cell Carcinoma.Cureus. 2023 Nov 1;15(11):e48137. doi: 10.7759/cureus.48137. eCollection 2023 Nov. Cureus. 2023. PMID: 38046721 Free PMC article.
References
-
- Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74–108. - PubMed
-
- Fuller CD, Wang SJ, Thomas CR, Jr, Hoffman HT, Weber RS, Rosenthal DI. Conditional survival in head and neck squamous cell carcinoma: results from the SEER dataset 1973–1998. Cancer. 2007;109:1331–1343. - PubMed
-
- Harris SL, Kimple RJ, Hayes DN, Couch ME, Rosenman JG. Never-smokers, never-drinkers: unique clinical subgroup of young patients with head and neck squamous cell cancers. Head Neck. 2010;32:499–503. - PubMed
-
- Chaturvedi AK, Engels EA, Anderson WF, Gillison ML. Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol. 2008;26:612–619. - PubMed
-
- Golas SM. Trends in palatine tonsillar cancer incidence and mortality rates in the United States. Community Dent Oral Epidemiol. 2007;35:98–108. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous